In the News 28th May

Thursdays News at a glance:

Center for Tobacco Products Research Priorities Do Not Include Studying Potential Benefits of E-Cigarettes for Smoking Cessation – An Outbreak Of Common Sense In New South Wales – Broader Implications of the Snus Decision – Big Tobacco fights back: how the cigarette kings bought the vaping industry – The research behind giving up cigarettes: a Q&A with leading expert Peter Hajek – Anti-smoking: ‘E’ is for ethics – Nicotine Science and Policy – Daily Digest – Thu, 28 May 2015

The Rest of the Story:

Center for Tobacco Products Research Priorities Do Not Include Studying Potential Benefits of E-Cigarettes for Smoking Cessation

While the FDA’s Center for Tobacco Products (CTP) has repeatedly claimed that it is intending to regulate e-cigarettes based on the results of scientific research, a close examination of the CTP’s research portfolio reveals that the agency is heavily funding research on the potential risks of e-cigarettes but does not have a single long-term clinical trial to evaluate the potential benefits of e-cigarettes for smoking cessation….

An Outbreak Of Common Sense In New South Wales

If you were up early enough this morning, you might have caught a proper liberal preparing to address a baying mob of authoritarian, tiny-minded snobs who seem intent on taking control of everyone’s freedom of choice. Peter Phelps is a government whip in the New South Wales parliament and a very sound beacon of sanity bobbing around in an ocean of proud fascists.

Big Tobacco fights back:

How the cigarette kings bought the vaping industry

At the end of 1999 Kingsley Wheaton found himself in the middle of a coup d’état. At 23, he had joined the cigarette manufacturer Rothmans, who sent him to Dubai. When British American Tobacco acquired Rothmans, Wheaton was given the option of relocating to West Africa. He moved to Abidjan, the commercial capital of Ivory Coast, to promote a portfolio of brands including Craven A, Benson & Hedges and Rothmans….

The research behind giving up cigarettes:

A Q&A with leading expert Peter Hajek

Peter Hajek, from the Wolfson Institute of Preventive Medicine at Queen Mary University of London, is a leading expert on the behavioral and pharmacological treatments associated with giving up smoking.

We asked Peter more about the treatments that are currently accessible to smokers trying to quit, the work that he has published on the topic and what he thinks the future will bring for smoking cessation….

Anti-smoking: ‘E’ is for ethics

Smoking is a global killer epidemic. During the 20th century tobacco caused 100 million death – roughly the same number as people killed in both World Wars. Without action, this century it could claim the lives of a billion people, mostly in low and middle income countries. Yet tackling smoking is a tricky business. Regulation must balance several fundamental principles: protecting people from harm whilst preserving human dignity and freedoms.

Broader Implications of the Snus Decision

One of the more surprising omissions from last months’ NATO Show was the fact that U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) director Mitch Zeller neglected to weigh in on the recent decision by a TPSAC (Tobacco Products Scientific Advisory Committee) panel to reject Swedish Match AB’s application to market their snus moist smokeless tobacco products as less harmful than cigarettes.

 Nicotine Science and Policy – Daily Digest – Thu, 28 May 2015